Patrick Soon-Shiong: NK cells matter!
Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation and Executive Chairman ImmunityBio, shared on X:
“Next week we will share our data in 86 patients with lung cancer who failed chemo and some who failed both chemo and radiation and all 86 who progressed on checkpoints. Our study involved accepting these 2nd and 3rd line patients and WHILE THEY WERE STILL PROGRESSING on the checkpoint, to add the Bioshield and then measure for overall survival with the same checkpoint plus Bioshield.
The test was: did lymphocytes ( NK cells and T cells) matter and could these patients be rescued after 2nd and 3rd line therapy even after destruction of their immune system by current standards of care.
Data coming: NK cells matter!!
But why are we waiting to catch patients once they already in a deep hole? Why not protect their cells from the outset?”
More posts featuring Patrick Soon-Shiong.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023